Ruan Xiangcai, Darwiche Sophie S, Cai Changchun, Scott Melanie J, Pape Hans-Christoph, Billiar Timothy R
Department of Anesthesiology, First Municipal People's Hospital of Guangzhou, Affiliated Hospital of Guangzhou Medical College, Guangzhou, China ; Department of Surgery, University of Pittsburgh, University of Pittsburgh Medical Center, Suite F1281, 200 Lothrop Street, Pittsburgh, PA 15213, USA.
Department of Surgery, University of Pittsburgh, University of Pittsburgh Medical Center, Suite F1281, 200 Lothrop Street, Pittsburgh, PA 15213, USA.
Mediators Inflamm. 2015;2015:458626. doi: 10.1155/2015/458626. Epub 2015 Jan 29.
Although tissue-derived high mobility group box 1 (HMGB1) is involved in many aspects of inflammation and tissue injury after trauma, its role in trauma-induced immune suppression remains elusive. Using an established mouse model of peripheral tissue trauma, which includes soft tissue and fracture components, we report here that treatment with anti-HMGB1 monoclonal antibody ameliorated the trauma-induced attenuated T-cell responses and accumulation of CD11b(+)Gr-1(+) myeloid-derived suppressor cells in the spleens seen two days after injury. Our data suggest that HMGB1 released after tissue trauma contributes to signaling pathways that lead to attenuation of T-lymphocyte responses and enhancement of myeloid-derived suppressor cell expansion.
尽管组织来源的高迁移率族蛋白B1(HMGB1)参与创伤后炎症和组织损伤的多个方面,但其在创伤诱导的免疫抑制中的作用仍不清楚。利用已建立的外周组织创伤小鼠模型(包括软组织和骨折成分),我们在此报告,抗HMGB1单克隆抗体治疗改善了创伤诱导的T细胞反应减弱以及损伤后两天在脾脏中出现的CD11b(+)Gr-1(+)髓源性抑制细胞的积累。我们的数据表明,组织创伤后释放的HMGB1有助于导致T淋巴细胞反应减弱和髓源性抑制细胞扩增增强的信号通路。